MORO, Laura
 Distribuzione geografica
Continente #
EU - Europa 1.665
NA - Nord America 1.498
AS - Asia 342
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 3.509
Nazione #
US - Stati Uniti d'America 1.485
IE - Irlanda 516
SE - Svezia 290
DE - Germania 269
IT - Italia 195
UA - Ucraina 186
FI - Finlandia 109
CN - Cina 98
SG - Singapore 98
HK - Hong Kong 52
IN - India 51
GB - Regno Unito 50
FR - Francia 20
TR - Turchia 17
IR - Iran 16
BE - Belgio 13
CA - Canada 13
VN - Vietnam 8
CH - Svizzera 3
CZ - Repubblica Ceca 3
RU - Federazione Russa 3
EU - Europa 2
LT - Lituania 2
RO - Romania 2
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
JP - Giappone 1
MA - Marocco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
Totale 3.509
Città #
Dublin 513
Jacksonville 339
Dearborn 155
Chandler 146
Wilmington 78
Ann Arbor 72
Singapore 66
Piemonte 63
Lawrence 59
Princeton 59
Hong Kong 52
Beijing 49
Andover 41
Bremen 33
San Mateo 32
Ashburn 28
Boardman 28
Woodbridge 20
Kocaeli 17
Strasbourg 17
Milan 16
Philadelphia 16
Brussels 13
Munich 12
Norwalk 12
Düsseldorf 11
Helsinki 10
Houston 10
Kunming 9
Turin 9
Zanjan 9
Dong Ket 8
Nanjing 8
Casalecchio Di Reno 7
Santa Clara 7
Fairfield 6
Hefei 6
Novara 6
Toronto 6
Bari 5
Leawood 5
Monmouth Junction 5
Sacramento 5
Vercelli 5
Fuzhou 4
Grafing 4
Henderson 4
Jinan 4
Mülheim 4
Winnipeg 4
Arcene 3
Baotou 3
Brno 3
Castelnuovo Scrivia 3
Nanchang 3
Portland 3
Rome 3
Shenyang 3
Bologna 2
Des Moines 2
Espoo 2
Falkenstein 2
Ottawa 2
Seattle 2
Shaoxing 2
Zurich 2
Ardabil 1
Ariano Irpino 1
Athens 1
Bangalore 1
Berlin 1
Biella 1
Borgomanero 1
Bresso 1
Cambridge 1
Catania 1
Cento 1
Chengdu 1
Chisinau 1
Chongqing 1
Clearwater 1
Erding 1
Frankfurt am Main 1
Hamilton 1
Horia 1
Huddersfield 1
Islamabad 1
Lanzhou 1
Lausanne 1
London 1
Mumbai 1
Nanning 1
Nepi 1
Perm 1
San Diego 1
Segrate 1
Shannon 1
Torino 1
Valladolid 1
Vigonza 1
Totale 2.171
Nome #
Pharmaceutical combinations comprising estrogen receptor-beta agonists with platinum drugs or paclitaxel for treating ovarian cancer 89
PARP1 inhibition affects Pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1 84
SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells. 84
Correction of the defective extracellular matrix of Ehlers-Danlos syndrome fibroblasts by Dexamethasone 83
Study of stromelysin-1 and fibronectin genes in a family with recurrent epidermolysis bullosa dystrophica recessive 79
Down-regulation by adherent cells of NK activity mediated by cord blood mononuclear cells 77
Regional mapping of the human Placental Alkaline Phosphatase (ALPP) gene to 2q37 band by in situ hybridization 72
Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia 72
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 68
Estrogenic analogues synthesized by click chemistry 67
Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality 66
Altered fibronectin mRNA splicing in skin fibroblasts from Ehlers-Danlos syndrome patients: in situ hybridization analysis 64
LE INTEGRINE E I FATTORI DI CRESCITA ATTRAVERSO DIFFERENTI MECCANISMI PROTEGGONO DALL'APOPTOSI LE CELLULE DI NEUROBLASTOMA COLTIVATE IN SOSPENSIONE 64
Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells 63
Quantitative evaluation of mRNAs by in situ hybridization and image analysis: principles and applications 62
Genomic organization and chromosomal localization of the gene encoding human beta adducin 62
Phenotypic correction of the defective fibronectin extracellular matrix of Elhers-Danlos syndrome fibroblasts 62
Angiokeratoma corporis diffusum and antero-venous fistulas with dominant trasmission in the absence of metabolic disorders 61
8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3OH kinase activity 61
RIDOTTA ADESIONE DEI FIBROBLASTI OTTENUTI DA PAZIENTI AFFETTI DA PSORIASI VOLGARE ALLE PROTEINE DELLA MATRICE EXTRACELLULARE, EFFETTO DELL'ACIDO RETINOICO 60
Study of fibronectin expression in tumor cells by dot-blot and in situ hybridization: quantitative evaluation by image analysis 58
Inhibition of the histone methyltransferase ezh2 enhances protumor monocyte recruitment in human mesothelioma spheroids 58
Expression of fibronectin and collagen I in skin fibroblasts from Ehlers-Danlos syndrome patients 57
8-Prenylnaringenin inhibits estrogen receptor-alpha mediated cell growth and induces apoptosis in MCF-7 breast cancer cells 57
Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter 57
Expression and therapeutic significance of estrogen receptor beta (ERβ) in malignant pleural mesothelioma 57
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 56
INTEGRIN-DEPENDENT EGF RECEPTOR ACTIVATION AS A NOVEL SIGNALING MECHANISM INVOLVED IN CELL SURVIVAL AND PROLIFERATION 55
Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability 55
Estrogen receptor beta agonists for use in treating mesothelioma 55
KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma 55
Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency 55
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma 54
Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway 53
Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings 53
Circulating tumor cells as a diagnostic test for malignant pleural mesothelioma 53
Study of fibronectin mRNA in human laryngeal and ectocervical carcinomas by in situ hybridization and image analysis 51
17beta-estradiol potentiates thrombin-dependent alfaIIbbeta3 activation and platelet aggregation 51
Flavonoid-induced autophagy in hormone-sensitive breast cancer cells 51
ESTROGEN RECEPTOR ß ACTIVATION IMPAIRS MITOCHONDRIAL OXIDATIVE METABOLISM AND AFFECTS MALIGNANT MESOTHELIOMA CELL GROWTH IN VITRO AND IN VIVO 51
Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity 51
Estrogen receptor beta impacts on prognosis of human malignant mesothelioma 50
Therapies currently in phase II trials for malignant mesothelioma 50
Integrin induce activation of EGF receptor: role in MAP Kinase induction and adhesion-dependent cell survival 48
Estrogen receptor beta exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib 48
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment 48
Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival 47
Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cells 47
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review 47
Ibridazione in situ quantitativa per lo studio dell'espressione genica in colture cellulari e in sezioni di tessuto 46
Clinical and genetic characterization of a Chanarin Dorfman Syndrome patient born to diseased parents 46
Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement 45
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition 45
Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells 44
Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase 43
Convergence of integrins and EGF receptor signalling via PI3K / AKT /FoxO pathway in early gene Egr-1 transcription 42
CDKN2A determines mesothelioma cell fate to EZH2 inhibition 42
Integrin-dependent regulation of EGF receptor and of EGF-dependent responses 40
p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells 39
Clinical and genetic characterization of Chanarin-Dorfman Syndrome patients: first report of large deletions in the ABHD5 gene 38
Integrin-induced EGF receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines 36
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 36
A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings 35
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment 34
A novel ABHD5 mutation in two Chanarin Dorfman siblings with severe and heterogeneous clinical phenotype 19
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma 15
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake 13
Totale 3.586
Categoria #
all - tutte 20.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020588 0 0 0 0 96 100 128 25 68 77 91 3
2020/2021484 63 5 61 4 52 4 63 4 63 67 76 22
2021/2022503 22 6 82 63 11 0 42 8 30 15 123 101
2022/20231.158 72 38 49 60 87 126 12 69 550 14 50 31
2023/2024307 42 19 35 15 66 2 49 8 1 4 23 43
2024/2025131 10 12 72 28 9 0 0 0 0 0 0 0
Totale 3.586